Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Clinical Trials in China / NCT06145932
Recruiting Not applicable

Repetitive Transcranial Magnetic Stimulation Therapy in Essential Tremor

NCT06145932 · tracked via the Priya Life Science China tracker
Sponsor
Second Affiliated Hospital of Soochow University
Phase
Not applicable
Started
2023-11-07
Last updated
2023-11-24

Condition(s) studied

Essential Tremor

Investigational drug(s) / intervention(s)

real rTMSsham rTMS

real rTMS: treated with 1HZ rTMS 1800 pulses / day,for 10 days

sham rTMS: treated with sham rTMS 1800 pulses / day,for 10 days

Study summary

The purpose of this study is to evaluate the efficacy and electrophysiology of repetitive transcranial magnetic stimulation in the treatment of essential tremor.

Eligibility

Sex
ALL
Min age
18 Years
Max age
80 Years
Healthy volunteers
No
Inclusion Criteria: 1. Diagnosed as essential tremor conforming to the diagnostic criteria for essential tremor in the tremor group of the International Parkinson's and Movement Disorders Society (IPMDS). 2. Signed informed consent form. Exclusion Criteria: 1. Complicated with brain organic diseases, epilepsy, other mental diseases, family history of dementia, metal devices implanted in the body and any contraindications to TMS; 2. History of craniocerebral surgery; 3. TMS cannot cooperate; 4. TMS-EEG examination artifacts are obvious, or cannot be analyzed due to other technical reasons.

Primary outcome measure(s)

  • The efficacy of the treatment on the essential tremor evaluated by Essential Tremor Rating Assessment Scale (TETRAS) score — visit 1(baseline), visit 2(Day 10), visit 3(Day 30)
    The TETRAS is widely used tremor evaluation scale.TETRAS has been used for evaluation tremor in patients with essential tremor focuses primarily on the assessment of activities of daily living and tremor.The TETRAS score ranges from 0 to 112. The higher the TETRAS score, the more severe the symptoms.
  • Changes from baseline in tremor analysis — visit 1(baseline), visit 2(Day 10), visit 3(Day 30)
    This outcome reflects quantitative changes in the patient's tremor.

Trial sites (1)

FacilityCityRegionStatus
The Second Affiliated Hospital of Soochow University Suzhou China Recruiting

More Second Affiliated Hospital of Soochow University trials in China

Plasma cfDNA Testing Guiding the Treatment Decisions of DLBCL Starting soon
Light Therapy in Parkinson's Disease Recruiting
Evaluation of the Effect of Cordycepin on CD8+ Lymphocytopenia in Patients With Solid Tumors Recruiting
Cetuximab β Combined With PRaG Regimen in the Treatment of EGFR-positive Advanced Refractory Solid Tumors Starting soon
Evaluation of the Effect of Finerenone on Renal Function in Patients With Type 2 Diabetes and Chronic Kidney Disease Recruiting

Other trials for the same condition

Temporal Interference for Essential Tremor Recruiting
Chinese ET Registry (CETR) Recruiting
A Study to Evaluate the Safety and Efficacy of Staged Bilateral Magnetic Resonance-Guided Focused Ultrasound Thalamotomy for the Treatment of Essential Tremor Enrolling by invitation
Safety and Effectiveness of Unilateral MR-Guided Focused Ultrasound Thalamotomy for Essential Tremor Starting soon
Non-Invasive Neuromodulation for Essential Tremor: Long-Term Safety and Effectiveness Study Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06145932 on ClinicalTrials.gov ↗ ← All trials in China